Elagolix - Abbvie/Neurocrine Biosciences
At a glance
- Drug Originator Icahn School of Medicine at Mount Sinai
- Drug Licenced by AbbVie; Neurocrine Biosciences
- Drug Class Analgesics; Antineoplastics; Fluorinated hydrocarbons; Pyrimidines; Small molecules
- Mechanism of Action LHRH receptor antagonists
- USA Patent Applicants ABBVIE
- USA Patents 17
- NDAs 1
- International Patents 103
- Patent Applications 151
Disclaimer